Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis

Journal of Neuroimmunology

Volumn 187, Issue 1-2, 2007, Pages 179-186

  Fabriek, Babs O ^a   Møller, Holger J ^b   Vloet, Rianka P M ^a   van Winsen, Lisa M ^a   Hanemaaijer, Roeland ^c   Teunissen, Charlotte E ^a   Uitdehaag, Bernard M J ^a   van den Berg, Timo K ^a   Dijkstra, Christine D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c TNO   (Netherlands)

Author keywords

CD163; Metalloproteinase; Monocytes; Multiple sclerosis; Scavenger receptor; sCD163

Indexed keywords

CD163 ANTIGEN; CYTOKINE; GELATINASE B; SCAVENGER RECEPTOR;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL LINE, TRANSFORMED; CRICETINAE; CRICETULUS; CYTOKINES; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCORTISONE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, CELL SURFACE; STATISTICS, NONPARAMETRIC; TRANSFECTION;

EID: 34347270538     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.04.016     Document Type: Article

References (39)

1. Aristoteli L.P., Moller H.J., Bailey B., Moestrup S.K., and Kritharides L. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis 148 2 (2006) 342-347
2. Axelsson J., Moller H.J., Witasp A., Qureshi A.R., Carrero J.J., Heimburger O., Barany P., Alvestrand A., Lindholm B., Moestrup S.K., and Stenvinkel P. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am. J. Kidney Dis. 48 6 (2006) 916-925
3. Baeten D., Moller H.J., Delanghe J., Veys E.M., Moestrup S.K., and De Keyser F. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum. 50 (2004) 1611-1623
4. Bleesing J., Prada A., Siegel D.M., Villanueva J., Olson J., Ilowite N.T., Brunner H.I., Griffin T., Graham T.B., Sherry D.D., Passo M.H., Ramanan A.V., Filipovich A., and Grom A.A. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 56 3 (2007) 965-971
5. Boven L.A., van Meurs M., van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., and Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129 (2006) 517-526
6. Daly A., Walsh C., Feighery C., O'Shea U., Jackson J., and Whelan A. Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease. Aliment. Pharmacol. Ther. 24 3 (2006) 553-559
7. De Groot C.J., Bergers E., Kamphorst W., Ravid R., Polman C.H., Barkhof F., and van der Valk P. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 124 (2001) 1635-1645
8. Droste A., Sorg C., and Hogger P. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem. Biophys. Res. Commun. 256 (1999) 110-113
9. Fabriek B.O., van Haastert E.S., Galea I., Polfliet M.M., Dopp E.D., van den Heuvel M.M., van den Berg T.K., de Groot C.J., van der Valk P., and Dijkstra C.D. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 51 (2005) 297-305
10. Frings W., Dreier J., and Sorg C. Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett. 526 (2002) 93-96
11. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003) 23-35
12. Hanemaaijer R., Visser H., Konttinen Y.T., Koolwijk P., and Verheijen J.H. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjogren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol. 17 (1998) 657-665
13. Hintz K.A., Rassias A.J., Wardwell K., Moss M.L., Morganelli P.M., Pioli P.A., Givan A.L., Wallace P.K., Yeager M.P., and Guyre P.M. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J. Leukoc. Biol. 72 (2002) 711-717
14. Hiraoka A., Horiike N., Akbar S.M., Michitaka K., Matsuyama T., and Onji M. Soluble CD163 in patients with liver disease: very high levels of soluble CD163 in patients with fulminant hepatic failure. J. Gastroenterol. 40 (2005) 52-56
15. Hogger P., Dreier J., Droste A., Buck F., and Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161 (1998) 1883-1890
16. Hogger P., and Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem. Biophys. Res. Commun. 288 (2001) 841-843
17. Jordens R., Thompson A., Amons R., and Koning F. Human dendritic cells shed a functional, soluble form of the mannose receptor. Int. Immunol. 11 (1999) 1775-1780
18. Knudsen T.B., Gustafson P., Kronborg G., Kristiansen T.B., Moestrup S.K., Nielsen J.O., Gomes V., Aaby P., Lisse I., Moller H.J., and Eugen-Olsen J. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin. Microbiol. Infect. 11 9 (2005) 730-735
19. Kowal K., Moller H.J., Dubuske L.M., Moestrup S.K., and Bodzenta-Lukaszyk A. Differential expression of monocyte CD163 in single-and dual-asthmatic responders during allergen-induced bronchoconstriction. Clin. Exp. Allergy 36 12 (2006) 1584-1591
20. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., and Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 409 (2001) 198-201
21. Lichtinghagen R., Seifert T., Kracke A., Marckmann S., Wurster U., and Heidenreich F. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J. Neuroimmunol. 99 (1999) 19-26
22. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
23. Madsen M., Moller H.J., Nielsen M.J., Jacobsen C., Graversen J.H., van den Berg S.K., and Moestrup S.K. Molecular characterization of the haptoglobin hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region. J. Biol. Chem. 279 (2004) 51561-51567
24. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
25. Martinez-Pomares L., Mahoney J.A., Kaposzta R., Linehan S.A., Stahl P.D., and Gordon S. A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum. J. Biol. Chem. 273 (1998) 23376-23380
26. Matsushita N., Kashiwagi M., Wait R., Nagayoshi R., Nakamura M., Matsuda T., Hogger P., Guyre P.M., Nagase H., and Matsuyama T. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin. Exp. Immunol. 130 (2002) 156-161
27. Moestrup S.K., and Moller H.J. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med. 36 (2004) 347-354
28. Moller H.J., Aerts H., Gronbaek H., Peterslund N.A., Hyltoft Petersen P., Hornung N., Rejnmark L., Jabbarpour E., and Moestrup S.K. Soluble CD163: a marker molecule for monocyte/macrophage activity in disease. Scand. J. Clin. Lab. Invest., Suppl. (2002) 29-33
29. Moller H.J., Hald K., and Moestrup S.K. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J. Clin. Lab. Invest. 62 (2002) 293-299
30. Moller H.J., Peterslund N.A., Graversen J.H., and Moestrup S.K. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 99 (2002) 378-380
31. Moller H.J., de Fost M., Aerts H., Hollak C., and Moestrup S.K. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur. J. Haematol. 72 (2004) 135-139
32. Moller H.J., Moestrup S.K., Weis N., Wejse C., Nielsen H., Pedersen S.S., Attermann J., Nexo E., and Kronborg G. Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit. Care Med. 34 (2006) 2561-2566
33. Philippidis P., Mason J.C., Evans B.J., Nadra I., Taylor K.M., Haskard D.O., and Landis R.C. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ. Res. 94 (2004) 119-126
34. Schaer D.J., Schleiffenbaum B., Kurrer M., Imhof A., Bächli E., Fehr J., Moller H.J., Moestrop S.K., and Schaffner A. Soluble haemoglobin-haptoglobin scavenger receptor CD163 as a lineage specific marker in the reactive hemophagocytic syndrome. Eur. J. Haematol. 74 (2005) 6-10
35. Timmermann M., and Hogger P. Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Free Radic. Biol. Med. 39 (2005) 98-107
36. Van den Heuvel M.M., Tensen C.P., van As J.H., van den Berg T.K., Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., van Gaalen F.A., Sorg C., Hogger P., and Beelen R.H. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J. Leukoc. Biol. 66 (1999) 858-866
37. Vogel I., Grove J., Thorsen P., Moestrup S.K., Uldbjerg N., and Moller H.J. Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery. BJOG 112 6 (2005) 737-742
38. Weiss M., and Schneider E.M. Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis. Crit. Care Med. 34 (2006) 2682-2683
39. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2 (2001) 502-511